Computer Assisted Cognitive Rehabilitation for Persons With Multiple Sclerosis



Status:Active, not recruiting
Conditions:Neurology, Neurology, Multiple Sclerosis
Therapuetic Areas:Neurology, Other
Healthy:No
Age Range:18 - 60
Updated:11/16/2017
Start Date:January 2014
End Date:June 2018

Use our guide to learn which trials are right for you!

The effects of multiple sclerosis (MS) on cognition, thought to occur in 50-75% of persons
with MS, have gained increasing recognition as one of the major disabling symptoms of the
disease. While numerous studies have addressed the emotional and physical impact of MS,
little attention has been given to strategies that might help manage the cognitive changes
commonly experienced by persons with MS. The proposed study will test a novel
computer-assisted cognitive rehabilitation intervention, MAPSS-MS (Memory, Attention, &
Problem Solving Skills for Persons with MS). The MAPSS-MS integrates the powerful effects of
group interventions to build self-efficacy for new cognitive compensatory
strategies/behaviors with individual home-based computer-assisted training. The computer
training will assist individuals to develop cognitive skills that they can apply to everyday
life using the compensatory strategies learned in the class sessions. In the recently
completed exploratory study with 61 persons with MS (R21NR011076), the eight-week MAPSS-MS
intervention was acceptable and feasible and had medium to large effects on the use of
compensatory strategies and performance on neuropsychological tests of verbal memory. The
proposed study will test the refined MAPSS-MS intervention with a larger more diverse sample
(N=180) across multiple sites, extend the period of post-intervention follow-up to 6 months
and establish whether performance improvements on neuropsychological tests make the important
transfer to improved neuro-cognitive functioning in everyday life.

The specific aims of this study are to: (1) Evaluate the efficacy of the novel MAPSS-MS
cognitive rehabilitation intervention to improve overall neuro-cognitive competence in
activities of daily living including verbal memory performance, use of compensatory cognitive
strategies and performance on cognitive-related instrumental activities of daily living
(IADL) among persons with MS; (2) Evaluate the efficacy of the MAPSS-MS intervention to
improve self-efficacy and related aspects of cognitive performance (non-verbal
learning/memory, information processing speed and attention, verbal fluency and complex
scanning and tracking) among persons with MS; and (3) Determine the number of intervention
participants who achieve and maintain their self-identified cognitive goals three and six
months following the intervention. The effects of the intervention on outcome variables will
be assessed using a randomized controlled trial design with a comparison group receiving
usual care computer games. Measurements of study variables will occur at baseline,
immediately after the MAPSS-MS intervention, and three months and six months after the
intervention is complete. Statistical analysis will include descriptive statistics and HLM
analysis to account for the nested design. The intent-to-treat approach will be used.

Public Health Statement: This research will provide new knowledge about an innovative
intervention to improve memory, use of compensatory strategies, and performance of cognitive
activities and instrumental activities of daily living for persons with MS. If effective, the
intervention would provide a new and feasible approach to target a serious, debilitating
problem commonly experienced by persons with MS.


Inclusion Criteria:

- Clinically definite diagnosis of MS;

- Age 18 to 60;

- Capable of understanding and complying with the study protocol;

- Able to read and write in English;

- Visual acuity of at least 20/70 with correction in order to work on the computer
screen;

- Stable disease at the time of entry into the study (relapse free for at least 90
days);

- Subjective concerns about their cognitive functioning (based on the Perceived Deficits
Questionnaire); and

- Home internet access;

Exclusion Criteria:

- Other medical causes of dementia or other neurological disorders that may impact
cognition or emotions;

- Evidence of major psychiatric disorder; or

- Major functional limitations that preclude them from participating in the study.
We found this trial at
1
site
Austin, Texas 78712
Principal Investigator: Alexa Stuifbergen, PhD, RN
Phone: 512-471-4100
?
mi
from
Austin, TX
Click here to add this to my saved trials